menu
    • menu

    Company profile for Noramco

    Noramco-PSE
    News
    Diversifying the Supply of Raw Materials

    12 Jun 2024

    // PRESS RELEASE

    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group

    15 Mar 2024

    // PRESS RELEASE

    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

    02 Nov 2023

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Normaco

    Contact Supplier

    Website

    American Pharma Summit

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

    Related CompaniesRelated Companies

    About

    Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and manufacturing, Noramco offers services like supply-chain integration for high-purity controlled substances, efficient routes to APIs, analytical data, stability studies, regulatory help, formulation-friendly particle size grades, extended technical packages, DEA-compliant security and production capacity from kilos to multi-ton supply. Noramco also offers world-class supply security for controlled substances, from Schedule I to Schedule III.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NoramcoUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    500 Swedes Landing Rd, Wilmington, DE 19801
    Telephone
    Telephone
    +1 3026523840
    Client Email
    Email
    aambrosi@Noramco.com
    Client Website
    Website
    https://www.noramco.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/noramco-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-87243.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-64446.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DMF Submitted for Lisdexamfetamine Dimesylate API

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-1638594073.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Small Volume Manufacture of APIs 2020

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-1582542575.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Reference Standards List 2020

    read-more

      https://www.pharmacompass.com/pdf/party/content/noramco-party-content-1582615883.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Diversifying the Supply of Raw Materials
    Diversifying the Supply of Raw Materials

    12 Jun 2024

    // PRESS RELEASE

    https://www.noramco.com/2024/06/12/diversifying-the-supply-of-raw-materials/

    PRESS RELEASE
    12 Jun 2024
    Share Share
    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group
    Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group

    15 Mar 2024

    // PRESS RELEASE

    https://www.noramco.com/2024/03/14/noramco-announces-strategic-alignment-with-purisys-and-halo-pharma/

    PRESS RELEASE
    15 Mar 2024
    Share Share
    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
    Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

    02 Nov 2023

    // PRESS RELEASE

    https://www.noramco.com/2023/11/02/noramco-announces-the-acquisition-of-the-cambrex-drug-product-business-unit/

    PRESS RELEASE
    02 Nov 2023
    Share Share
    Noramco Announces Submission & Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
    Noramco Announces Submission & Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

    01 Nov 2022

    // PRESS RELEASE

    https://www.noramco.com/2022/11/01/noramco-announces-submission-and-reactivation-of-the-drug-master-file-for-active-pharmaceutical-ingredient-methylnaltrexone-bromide/

    PRESS RELEASE
    01 Nov 2022
    Share Share
    Noramco Celebrates Diversity and International Women’s Day
    Noramco Celebrates Diversity and International Women’s Day

    07 Mar 2022

    // Randolph Ramirez PRESS RELEASE

    https://www.noramco.com/2022/03/07/noramco-celebrates-diversity-and-international-womens-day/

    Randolph Ramirez PRESS RELEASE
    07 Mar 2022
    Share Share
    Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate
    Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate

    03 Dec 2021

    // PRESS RELEASE

    https://www.noramco.com/2021/12/03/noramco-lisdexamfetamine-dmf-submission/

    PRESS RELEASE
    03 Dec 2021
    Share Share

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    REF. STANDARDS & IMPURITIES

    Check the ref. standards & impurities from this company

    Inspections and registrations

    Check the inspections & registration from this company

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    arrow
    Compamed
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2019-02-21

    Noramco

    City : Wilmington

    State : DE

    Country/Area : US

    Zip : 19801-4417

    District : PHI

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2019-02-21

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    arrow
    Compamed
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-11-17

    Noramco

    City : Wilmington

    State : DE

    Country/Area : US

    Zip : 19801-4417

    District : PHI

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-11-17

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    arrow
    Compamed
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2016-01-21

    Noramco

    City : Wilmington

    State : DE

    Country/Area : US

    Zip : 19801-4417

    District : PHI

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2016-01-21

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    arrow
    Compamed
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-08-02

    Noramco

    City : Wilmington

    State : DE

    Country/Area : US

    Zip : 19801-4417

    District : PHI

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-08-02

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    arrow
    Compamed
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2012-04-27

    Noramco

    City : Wilmington

    State : DE

    Country/Area : US

    Zip : 19801-4417

    District : PHI

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2012-04-27

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    arrow
    Compamed
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-11-13

    Noramco

    City : Wilmington

    State : DE

    Country/Area : US

    Zip : 19801-4417

    District : PHI

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-11-13

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    arrow
    Compamed
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2022-11-18

    Noramco

    City : Wilmington

    State : Delaware

    Country/Area : US

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2022-11-18

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    arrow
    Compamed
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2017-06-15

    Purisys LLC

    City : Athens

    State : GA

    Country/Area : US

    Zip : 30601-1602

    District : ATL

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2017-06-15

    Noramco

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Noramco Inc and get a quotation

    Noramco Inc is a supplier offers 24 products (APIs, Excipients or Intermediates).

    Find a price of Buprenorphine Hydrochloride bulk with DMF, CEP offered by Noramco Inc

    Find a price of Hydromorphone Hydrochloride bulk with DMF, CEP offered by Noramco Inc

    Find a price of Naloxone Hydrochloride bulk with DMF, CEP offered by Noramco Inc

    Find a price of Oxycodone Hydrochloride bulk with DMF, CEP offered by Noramco Inc

    Find a price of Buprenorphine bulk with DMF offered by Noramco Inc

    Find a price of Buprenorphine Hydrochloride bulk with DMF offered by Noramco Inc

    Find a price of Codeine Phosphate bulk with DMF offered by Noramco Inc

    Find a price of Hydrocodone Bitartrate bulk with DMF offered by Noramco Inc

    Find a price of Levorphanol Tartrate bulk with DMF offered by Noramco Inc

    Find a price of Lisdexamfetamine Dimesylate bulk with DMF offered by Noramco Inc

    Find a price of Methylphenidate Hydrochloride bulk with DMF offered by Noramco Inc

    Find a price of Morphine Sulfate bulk with DMF offered by Noramco Inc

    Find a price of Naltrexone bulk with DMF offered by Noramco Inc

    Find a price of Naltrexone Hydrochloride bulk with DMF offered by Noramco Inc

    Find a price of Naltrexone Methobromide bulk with DMF offered by Noramco Inc

    Find a price of Oxycodone Hydrochloride bulk with DMF offered by Noramco Inc

    Find a price of Oxymorphone Hydrochloride bulk with DMF offered by Noramco Inc

    Find a price of Tapentadol bulk with DMF offered by Noramco Inc

    Find a price of Cannabidiol bulk offered by Noramco Inc

    Find a price of Dexmethylphenidate bulk offered by Noramco Inc

    Find a price of Nabilone bulk offered by Noramco Inc

    Find a price of Oxymorphone bulk offered by Noramco Inc

    Find a price of Sodium Oxybate bulk offered by Noramco Inc

    Find a price of Tetrahydrocannabinol bulk offered by Noramco Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search